Formulated with 100% safe and nourishing ingredients for pregnancy, breastfeeding mothers, infants and sensitive skin sufferers. Can be used for long term treatment and prevention of dry skin due to ageing to restore optimal barrier function.
Ultra intensive skin moisturiser for total skin barrier repair with pharmaceutical grade ingredients. For all skin types, including dry / sensitive, combination and acne prone / oily skin.
This moisturiser is formulated as a Prescription Emollient Device (PED), the gold standard in eczema management¹, and also the optimal moisturer for barrier protection against maskne².
Phytoceramides [Skin Barrier Repair]
Plant Seed Oils [Anti-Cellulite]
Multi-Ceramide [Skin Lipid Restoration]
Sodium Hyaluronate [Hydration]
Steroid-free eczema treatment cream formulated with anti-inflammatory effects. PED formulation can minimise reliance on topical steroids with medium to long term use for chronic eczema patients.
Dermatologist formulated to treat eczema, dry sensitive skin and to prevent skin ageing. Botanically derived anti-oxidants to improve the appearance of cellulite. Suitable for face and body.
Read more about effects of Ceramides here.
DIRECTIONS FOR USE
Refrigerate for optimum effects on the skin. Can be stored safely also at room temperature.
[Intensive] Liberal amount entire affected area 5 times daily, to continue until symptoms resolve. Suitable for use during clinical treatment of eczema by dermatologist.
[Maintenance] Liberal amount entire body twice daily, use immediately after shower when skin is damp, for prevention of eczema recurrence and dry sensitive skin. Restores healthy skin barrier and prevents skin-ageing.
Monitor your clinical response with the Hydration Skin Analyzer – Skin Barrier Biosensor
- Eichenfield LF, Tom WL, Berger TG, et al. Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies. J Am Acad Dermatol. 2014;71(1):116-132. doi:10.1016/j.jaad.2014.03.023
- Teo WL. Diagnostic and Management Considerations for ‘Maskne’ in the Era of COVID-19 [published online ahead of print, 2020 Oct 1]. J Am Acad Dermatol. 2020;S0190-9622(20)32664-5. doi:10.1016/j.jaad.2020.09.063
AS SEEN ON